CN116869886B - Acne-removing composition, and preparation method and application thereof - Google Patents
Acne-removing composition, and preparation method and application thereof Download PDFInfo
- Publication number
- CN116869886B CN116869886B CN202310930353.0A CN202310930353A CN116869886B CN 116869886 B CN116869886 B CN 116869886B CN 202310930353 A CN202310930353 A CN 202310930353A CN 116869886 B CN116869886 B CN 116869886B
- Authority
- CN
- China
- Prior art keywords
- acne
- removing composition
- extract
- component
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 102
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 96
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000004375 Dextrin Substances 0.000 claims abstract description 19
- 229920001353 Dextrin Polymers 0.000 claims abstract description 19
- 235000019425 dextrin Nutrition 0.000 claims abstract description 19
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 19
- 235000003434 Sesamum indicum Nutrition 0.000 claims abstract description 17
- 150000001413 amino acids Chemical class 0.000 claims abstract description 17
- 241000028204 Vincetoxicum atratum Species 0.000 claims abstract description 16
- 244000146462 Centella asiatica Species 0.000 claims abstract description 15
- 235000004032 Centella asiatica Nutrition 0.000 claims abstract description 15
- 239000013543 active substance Substances 0.000 claims abstract description 15
- 239000002537 cosmetic Substances 0.000 claims abstract description 7
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 6
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 6
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 6
- 235000011477 liquorice Nutrition 0.000 claims abstract description 6
- 244000000231 Sesamum indicum Species 0.000 claims abstract 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 43
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 25
- 235000019198 oils Nutrition 0.000 claims description 24
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 235000011187 glycerol Nutrition 0.000 claims description 17
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 16
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 14
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 14
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 14
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 14
- 229960000367 inositol Drugs 0.000 claims description 14
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 14
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 13
- 229940075529 glyceryl stearate Drugs 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- -1 PEG-100 stearate Chemical compound 0.000 claims description 11
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 10
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 10
- 229940069445 licorice extract Drugs 0.000 claims description 10
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 10
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 claims description 9
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 9
- 230000003255 anti-acne Effects 0.000 claims description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 9
- 239000000230 xanthan gum Substances 0.000 claims description 9
- 229920001285 xanthan gum Polymers 0.000 claims description 9
- 235000010493 xanthan gum Nutrition 0.000 claims description 9
- 229940082509 xanthan gum Drugs 0.000 claims description 9
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 8
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 8
- 108010077895 Sarcosine Proteins 0.000 claims description 8
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 8
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 8
- 229940100460 peg-100 stearate Drugs 0.000 claims description 8
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 8
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 8
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 8
- 229940113124 polysorbate 60 Drugs 0.000 claims description 8
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 8
- 229940043230 sarcosine Drugs 0.000 claims description 8
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 8
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 7
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 claims description 7
- 229920002367 Polyisobutene Polymers 0.000 claims description 7
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 7
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 7
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 claims description 7
- 239000003463 adsorbent Substances 0.000 claims description 7
- 229960000458 allantoin Drugs 0.000 claims description 7
- 239000003906 humectant Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 7
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 7
- 229940068977 polysorbate 20 Drugs 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 229940057429 sorbitan isostearate Drugs 0.000 claims description 7
- 229950011392 sorbitan stearate Drugs 0.000 claims description 7
- 229930003799 tocopherol Natural products 0.000 claims description 7
- 235000010384 tocopherol Nutrition 0.000 claims description 7
- 229960001295 tocopherol Drugs 0.000 claims description 7
- 239000011732 tocopherol Substances 0.000 claims description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 7
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical group CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 6
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims description 6
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical group CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 6
- 235000021360 Myristic acid Nutrition 0.000 claims description 6
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 6
- 244000046101 Sophora japonica Species 0.000 claims description 6
- 235000010586 Sophora japonica Nutrition 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 6
- 229940041616 menthol Drugs 0.000 claims description 6
- 239000003381 stabilizer Substances 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 claims description 4
- 239000002738 chelating agent Substances 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000002826 coolant Substances 0.000 claims description 4
- 229940008099 dimethicone Drugs 0.000 claims description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- 239000003974 emollient agent Substances 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000004382 potting Methods 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 4
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000004945 emulsification Methods 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- BVCOHOSEBKQIQD-UHFFFAOYSA-N 2-tert-butyl-6-methoxyphenol Chemical compound COC1=CC=CC(C(C)(C)C)=C1O BVCOHOSEBKQIQD-UHFFFAOYSA-N 0.000 claims description 2
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 claims description 2
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 claims description 2
- 239000005639 Lauric acid Substances 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- 239000004264 Petrolatum Substances 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 244000044822 Simmondsia californica Species 0.000 claims description 2
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 235000013871 bee wax Nutrition 0.000 claims description 2
- 229940092738 beeswax Drugs 0.000 claims description 2
- 239000012166 beeswax Substances 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 230000003750 conditioning effect Effects 0.000 claims description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 2
- 229960000735 docosanol Drugs 0.000 claims description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 2
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 229930182478 glucoside Natural products 0.000 claims description 2
- 229940100463 hexyl laurate Drugs 0.000 claims description 2
- 229940072106 hydroxystearate Drugs 0.000 claims description 2
- 229940074928 isopropyl myristate Drugs 0.000 claims description 2
- 229940075495 isopropyl palmitate Drugs 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 229940057995 liquid paraffin Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229960000292 pectin Drugs 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 229940066842 petrolatum Drugs 0.000 claims description 2
- 235000019271 petrolatum Nutrition 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 229950008882 polysorbate Drugs 0.000 claims description 2
- 239000000473 propyl gallate Substances 0.000 claims description 2
- 235000010388 propyl gallate Nutrition 0.000 claims description 2
- 229940075579 propyl gallate Drugs 0.000 claims description 2
- 235000013772 propylene glycol Nutrition 0.000 claims description 2
- 229940083575 sodium dodecyl sulfate Drugs 0.000 claims description 2
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- 229940032094 squalane Drugs 0.000 claims description 2
- 229960004274 stearic acid Drugs 0.000 claims description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 claims description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 1
- QWQNFXDYOCUEER-UHFFFAOYSA-N 2,3-ditert-butyl-4-methylphenol Chemical compound CC1=CC=C(O)C(C(C)(C)C)=C1C(C)(C)C QWQNFXDYOCUEER-UHFFFAOYSA-N 0.000 claims 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 claims 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 claims 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 229940079886 disodium lauryl sulfosuccinate Drugs 0.000 claims 1
- KHIQYZGEUSTKSB-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O KHIQYZGEUSTKSB-UHFFFAOYSA-L 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 229960002442 glucosamine Drugs 0.000 claims 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 36
- 208000020154 Acnes Diseases 0.000 abstract description 8
- 241000219784 Sophora Species 0.000 abstract description 6
- 208000002193 Pain Diseases 0.000 abstract description 3
- 208000003251 Pruritus Diseases 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 231100000241 scar Toxicity 0.000 abstract description 3
- 208000032544 Cicatrix Diseases 0.000 abstract description 2
- 230000007803 itching Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000037387 scars Effects 0.000 abstract description 2
- 241000207961 Sesamum Species 0.000 description 13
- 210000002374 sebum Anatomy 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 241000186427 Cutibacterium acnes Species 0.000 description 6
- 229940055019 propionibacterium acne Drugs 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 235000003417 Plumeria rubra f acutifolia Nutrition 0.000 description 4
- 244000040691 Plumeria rubra f. acutifolia Species 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 229940059958 centella asiatica extract Drugs 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical class C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000001061 forehead Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- FBNAWLJSQORPAX-UHFFFAOYSA-N 4-methyl-3-propan-2-ylphenol Chemical compound CC(C)C1=CC(O)=CC=C1C FBNAWLJSQORPAX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 230000002910 effect on acne Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 238000013532 laser treatment Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- RXVBJUZEFSAYPW-UHFFFAOYSA-N 1,3-diphenylpropane-1,2,3-trione Chemical compound C=1C=CC=CC=1C(=O)C(=O)C(=O)C1=CC=CC=C1 RXVBJUZEFSAYPW-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000175448 Citrus madurensis Species 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 235000017317 Fortunella Nutrition 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007332 Podocarpus macrophyllus Species 0.000 description 1
- 235000016408 Podocarpus macrophyllus Nutrition 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- UDEWPOVQBGFNGE-UHFFFAOYSA-N benzoic acid n-propyl ester Natural products CCCOC(=O)C1=CC=CC=C1 UDEWPOVQBGFNGE-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229910003472 fullerene Inorganic materials 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- IPVSQRLZENDNRL-KVVVOXFISA-N hexadecanoic acid;(z)-octadec-9-enoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O IPVSQRLZENDNRL-KVVVOXFISA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- OLXYLDUSSBULGU-UHFFFAOYSA-N methyl pyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC=C1 OLXYLDUSSBULGU-UHFFFAOYSA-N 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229940064064 purslane extract Drugs 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940084038 salix alba bark extract Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Abstract
The invention provides an acne-removing composition, and a preparation method and application thereof, and belongs to the technical field of cosmetics. The acne-removing composition takes the cynanchum atratum extract, the centella asiatica root extract, the sophora flower extract and the liquorice extract as active substances, and other auxiliary materials are matched, so that the acne-removing composition has the effects of controlling oil and removing acnes, relieving pain and itching and repairing scars through reasonable proportion; the dextrin, the salicylic acid and the sesame amino acid are added into the acne-removing composition, so that the absorption and the utilization of the skin to the acne-removing composition can be improved, a greater effect is exerted, the stability of the product is improved, and the storage is convenient.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to an acne-removing composition, and a preparation method and application thereof.
Background
Acne is also called comedo, pimple, and the like, is a chronic skin inflammation, is well developed on the face, the upper chest and the back, and is mainly clinically manifested as comedo, pimple, pustule, nodule, and the like. The mechanism responsible for acne is mainly: sebum hypersecretion, obstruction of the pilosebaceous ducts, infection with bacteria, in particular propionibacterium acnes, and inflammatory reactions. Acne is also known as "whelk" because it is common in puberty. But acne not only appears in puberty, but also skin pores are easily blocked due to long-term contact of skin with dust in air, and skin barriers of human bodies are affected due to computer radiation, unhealthy life and the like, so that irregular skin metabolism is caused, and acne can be caused to grow.
The existing anti-acne method is many, such as laser treatment, can quickly destroy the acne propionate bacillus, effectively inhibit bacterial reproduction, eliminate the stimulation and damage to tissues, but the laser treatment has too strong effect and cannot radically remove acnes. If acid therapy is used, although the acid therapy has a certain inhibition effect on acne, the fruit acid has large irritation and strong side effect. If the medicine is used for treating the skin, the medicine has quick response, but the medicine resistance problem easily occurs, and the skin-dependent dermatitis is formed after long-term use. The acne-removing product such as acne-removing cream, acne-removing essence, acne-removing gel, acne-removing mask and the like is used for resisting acne, so that the acne-removing mask is mild and free of stimulation, and has a good effect. Therefore, the development of acne-removing products has been welcome.
For example, chinese patent CNCN105012347a discloses a skin repairing agent containing water-soluble derivatives of fullerene, which comprises water-soluble derivatives of fullerene, iodine stabilizer, iodine complexing agent, surfactant, organic acid, etc., wherein iodine complex component can kill bacteria, spores, protozoa, fungi, etc. infecting skin surface with high efficiency, gel component can protect wound from external pollution, create weak acidity and moist microenvironment which is favorable for wound healing, fullerene component has higher permeability, can be absorbed by organism transdermally, adsorb free radical in a great amount on wound layer, promote repair and regeneration of damaged cells, and obviously improve uncomfortable symptoms such as pruritus.
Also, as in chinese patent CN201410386421, a mild and effective composition for acne removal and oil control is disclosed, which comprises sodium hyaluronate, glycerin, propylene glycol, hydroxyethyl fiber, urea sacs, D-panthenol, podocarpus macrophyllus extract, ethanol, white willow bark extract, purslane extract, etc. The skin moisturizing and oil ester balancing agent has the main effects of improving the skin moisturizing effect, regulating the skin oil ester balance, inhibiting sebum transitional secretion, and inhibiting the propagation of propionibacterium acnes so as to achieve the effects of controlling oil and removing acnes.
However, the existing acne removing product is easy to generate skin injury, has insufficient repairing effect on acne marks and has insufficient acne removing effect. It is therefore necessary to develop a mildly effective anti-acne product.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides an acne removing composition, a preparation method and application thereof, and the acne removing composition can quickly permeate into skin through the matching of various active ingredients, achieves the purposes of safely and efficiently removing acnes, repairing skin and inhibiting the regeneration of acnes, is mild and non-irritating, and can relieve skin inflammation, inhibit sebum secretion and the like.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
an anti-acne composition comprises an active, an emulsifier, an emollient, a humectant, a surfactant, an antioxidant, a skin conditioning agent, an adsorbent, an emulsion stabilizer, a thickener, a preservative, a chelating agent, a cooling agent, a fragrance, and a solvent; wherein,
the active substance comprises cynanchum atratum extract, centella asiatica root extract, sophora flower extract and liquorice extract in a mass ratio of 10-20:60-75:8-15:4-10.
Further, the active substance comprises cynanchum atratum extract, centella asiatica root extract, sophora japonica extract and liquorice extract in a mass ratio of 10:16:70:4.
Further, the emulsifier is at least one of cetostearyl alcohol, polysorbate-60, glycerol stearate, PEG-100 stearate, sorbitan sesquioleate, dimerized hydroxystearate, behenyl alcohol and arachidic alcohol glucoside, lauric acid, myristic acid, palmitic acid, glycerol stearate and glycerol; preferably, the emulsifier is cetostearyl alcohol, polysorbate-60, glyceryl stearate/PEG-100 stearate, myristic acid/glyceryl stearate/glycerin, and the mass ratio is 3-5:1.5-3:0.8-2:0.2-0.8. Further preferably, the emulsifier is cetostearyl alcohol, polysorbate-60, glyceryl stearate/PEG-100 stearate, myristic acid/glyceryl stearate/glycerin, and is formulated according to a mass ratio of 4.4:2.5:2:0.55.
Further, the emollient is at least one of ethylhexyl palmitate, hexyl laurate, lauryl alcohol, squalane, caprylic triglyceride, capric triglyceride, polydimethylsiloxane and jojoba seed oil; ethylhexyl palmitate is preferred.
Further, the humectant is at least one of polydimethylsiloxane, glycerol, propylene glycol, butanediol, 1, 2-pentanediol, 1, 2-hexanediol, polyethylene glycol, quaternary ammonium salt-73, inositol, sarcosine, dipeptide-15, xylitol, sorbitol, sodium hyaluronate, isopropyl palmitate and hydrolyzed glucose aminoglycans; preferably, the humectant is polydimethylsiloxane, glycerol, butanediol/1, 2-pentanediol, propylene glycol/quaternary ammonium salt-73, 1, 2-hexanediol, inositol, butanediol/sarcosine/inositol/dipeptide-15, and the humectant is compounded according to the mass ratio of 1-2:3-6:1.5-3:1.3-2:0.2-0.6:0.2-0.6:0.3-0.8; further preferably, the humectant is polydimethylsiloxane, glycerol, butanediol/1, 2-pentanediol, propylene glycol/quaternary ammonium salt-73, 1, 2-hexanediol, inositol, butanediol/sarcosine/inositol/dipeptide-15, and the mass ratio is 1.7:4.2:2:2:0.4:0.5:0.5.
Further, the surfactant is at least one of sorbitan stearate, lauryl sulfonated disodium succinate, lecithin, stearic acid, sodium dodecyl benzene sulfonate, sodium dodecyl sulfate, polysorbate and fatty glyceride; sorbitan stearate is preferred.
Further, the antioxidant is at least one of p-hydroxyacetophenone, tocopherol (vitamin E), di-tert-butyl-p-cresol, tert-butyl hydroxyanisole and propylated edible acid salt; preferably, the antioxidant is compounded by p-hydroxyacetophenone and tocopherol according to the mass ratio of 0.2-0.6:0.1-0.5.
Further, the skin conditioner is at least one of allantoin, liquid paraffin, liquid petrolatum, isopropyl myristate, isopropyl palmitate, 2-ethylhexyl palmitate, unsaturated fatty acids such as oleic acid palmitic acid, stearic acid, behenic acid, and linoleic acid, preferably allantoin.
Further, the adsorbent comprises dextrin, salicylic acid and sesame amino acids in a mass ratio of 62.8-65.6:34-37:0.2-0.4; preferably, the adsorbent comprises dextrin, salicylic acid and sesame amino acids in a mass ratio of 64.8:35:0.2.
Further, the emulsion stabilizer is at least one of polyacrylate-13, polyisobutylene, sorbitan isostearate, polysorbate-20, vitamin E acetate, butylhydroxytoluene, tert-butyl p-methoxyphenol and propyl gallate; preferably, the emulsion stabilizer is prepared from polyacrylate-13, polyisobutylene, sorbitan isostearate and polysorbate-20 according to a mass ratio of 60:30:3:2.
Further, the thickener is at least one of isopropyl myristate, xanthan gum, beeswax, xanthan gum, acrylic acid polymer, carrageenan, carbomer, pectin and cellulose; preferably, the thickening agent is isopropyl myristate and xanthan gum in a mass ratio of 6-15:0.1-0.5.
Further, the preservative is at least one of o-cymene-5-alcohol, methyl benzoate, propyl benzoate, phenoxyethanol, ethylhexyl glycerol, tert-butylhydroquinone, benzoyl ketone and sodium benzoate; preferably, o-cymene-5-ol.
Further, the chelating agent is EDTA-disodium.
Further, the cooling agent is menthol.
Further, the essence is any one or more of cosmetics usable essence, including but not limited to lavender essence, lemon essence, jasmine essence, rose essence, camellia essence, kumquat essence, strawberry essence, juicy peach essence and grapefruit essence.
Further, the solvent is any one of deionized water, distilled water, ion-exchanged water, double distilled water, high-purity water, and purified water.
Preferably, the acne-removing composition comprises the following components in percentage by weight:
component A:6-15% isopropyl myristate, 3-5% cetostearyl alcohol, 1.5-4% ethylhexyl palmitate, 1.5-3% polysorbate-60, 0.8-2% glyceryl stearate/PEG-100 stearate, 1-2% dimethicone, 1.2-2% sorbitan stearate, 0.2-0.8% myristic acid/glyceryl stearate/glycerin, and 0.1-0.5% tocopherol;
component B:50-60% of solvent, 3-6% of glycerol, 0.2-0.6% of p-hydroxyacetophenone, 0.1-0.5% of xanthan gum, 0.1-0.3% of allantoin, 0.03-0.08% of cymene-5-ol and 0.02-0.06% of EDTA-disodium;
component C:1.5-3% dextrin/salicylic acid/sesame amino acids, 0.8-1.5% polyacrylate-13/polyisobutylene/sorbitan isostearate/polysorbate-20 and 0.1-0.3% menthol;
component D:0.25-0.56% water, 1.5-3% butanediol/1, 2-pentanediol, 2-5% active substance, 1.3-2% propylene glycol/quaternary ammonium salt-73, 0.2-0.6%1, 2-hexanediol, 0.2-0.6% inositol, 0.3-0.8% butanediol/sarcosine/inositol/dipeptide-15, and 0.1-0.3% essence.
Further preferably, the acne-removing composition comprises, in weight percent:
component A:10% isopropyl myristate, 4.4% cetostearyl alcohol, 3.5% ethylhexyl palmitate, 2.5% polysorbate-60, 2% glyceryl stearate/PEG-100 stearate, 1.7% dimethicone, 1.8% sorbitan stearate, 0.55% myristic acid/glyceryl stearate/glycerin, and 0.4% tocopherol;
component B:55% solvent, 4.2% glycerol, 0.3% p-hydroxyacetophenone, 0.3% xanthan gum, 0.2% allantoin, 0.05% cymene-5-ol and 0.04% edta-disodium;
component C:2% dextrin/salicylic acid/sesame amino acid, 1% polyacrylate-13/polyisobutylene/sorbitan isostearate/polysorbate-20, 0.2% menthol;
component D:0.36% water, 2% butanediol/1, 2-pentanediol, 4% active substance, 2% propylene glycol/quaternary ammonium salt-73, 0.3%1, 2-hexanediol, 0.5% inositol, 0.5% butanediol/sarcosine/inositol/dipeptide-15, and 0.2% perfume.
The invention also provides a preparation method of the acne-removing composition, which comprises the following steps:
(1) Adding the component A into an oil phase pot, and heating and uniformly stirring to obtain an oil phase mixed solution A;
(2) Adding the component B into a water phase pot, and heating and stirring uniformly to obtain a water phase mixed solution B;
(3) Preheating a reaction kettle, vacuumizing and sucking the oil phase mixed solution A and the water phase mixed solution B, and starting stirring to perform homogenizing emulsification;
(4) Adding the component C, stirring and uniformly mixing, and preserving heat;
(5) Cooling to 45-50deg.C, adding component D, and stirring to obtain acne removing composition.
Further, in the steps (1) and (2), the stirring speed is 150-300r/min, the stirring time is 5-30min, and the heating temperature is 75-85 ℃; preferably, the stirring speed is 200r/min, the stirring time is 10min, and the heating temperature is 80 ℃.
Further, in the step (3), the stirring speed is 350-500r/min, and the homogenizing and emulsifying time is 5-20min; preferably, the stirring speed is 400r/min, and the homogenizing emulsification time is 10min.
Further, in the step (4), the temperature is reduced to 48 ℃.
Further, in the step (4), the stirring speed is 350-500r/min, and the stirring time is 10-30min; preferably, the stirring speed is 400r/min and the stirring time is 20min.
Further, in the step (4), the heat preservation time is 15-30min, preferably 20min.
The invention also provides application of the acne-removing composition in preparing cosmetics.
Compared with the prior art, the invention has the following beneficial effects:
(1) The acne-removing composition is prepared by scientifically combining a plurality of active substances and auxiliary materials, and has the functions of removing acnes, relieving pain, relieving itching and repairing scars; through reasonable proportion, the acne-removing composition is easier to smear and absorb, achieves the purposes of safely and efficiently removing acnes, repairing skin and inhibiting the regeneration of acnes, is mild and non-irritating, and can effectively inhibit bacteria, relieve skin inflammation and inflammation, sebum secretion and the like.
(2) According to the invention, the cynanchum atratum extract, the centella asiatica root extract, the sophora flower extract and the liquorice extract are used as active substances, and the excellent antibacterial performance and acne-removing and oil-controlling effects can be obtained by optimizing the proportion of the four substances.
(3) According to the acne-removing composition, the dextrin, the salicylic acid and the sesame amino acid are added, and the proportion of the dextrin, the salicylic acid and the sesame amino acid is optimized, so that the skin can absorb and utilize the acne-removing composition, a greater effect is exerted, the stability of the acne-removing composition is improved, the acne-removing composition is convenient to store and carry, and the acne-removing composition can be placed for a long time in a high-low temperature environment.
Detailed Description
The following non-limiting examples will enable those of ordinary skill in the art to more fully understand the invention and are not intended to limit the invention in any way. The following is merely exemplary of the scope of the invention as claimed and many variations and modifications of the invention will be apparent to those skilled in the art in light of the disclosure, which are intended to be within the scope of the invention as claimed.
The invention is further illustrated by means of the following specific examples. The various chemical reagents used in the examples of the present invention were obtained by conventional commercial means unless otherwise specified.
Examples 1 to 5
The acne-removing composition has the formula shown in the following table 1:
TABLE 1
Wherein, in the example 1, the mass ratio of dextrin/salicylic acid/sesame amino acid is 62.8:37:0.2, and the mass ratio of cynanchum atratum extract/centella asiatica root extract/sophora flower extract/licorice extract is 10:75:5:10;
in example 2, the mass ratio of dextrin/salicylic acid/sesame amino acid is 64.8:35:0.2, and the mass ratio of cynanchum atratum extract/centella asiatica root extract/sophora flower extract/licorice extract is 10:70:16:4;
in example 3, the mass ratio of dextrin/salicylic acid/sesame amino acid was 65.6:34:0.4, and the mass ratio of cynanchum atratum extract/centella asiatica root extract/sophora flower extract/licorice extract was 20:60:10:10;
the mass ratio of dextrin/salicylic acid/sesame amino acid in examples 4 and 5 was the same as that in example 2, and the mass ratio of cynanchum atratum extract/centella asiatica root extract/sophora japonica extract/licorice extract was the same as that in example 2.
The preparation method of the acne-removing composition comprises the following steps:
(1) Adding the component A into an oil phase pot, heating to 80 ℃, stirring for 10min at 200r/min, and uniformly mixing to obtain an oil phase mixed solution A;
(2) Adding the component B into a water phase pot, heating to 80 ℃, stirring for 10min at 200r/min, and uniformly mixing to obtain a water phase mixed solution B;
(3) Preheating a reaction kettle, vacuumizing, sucking the oil phase mixed solution A and the water phase mixed solution B, and homogenizing and emulsifying for 10min at the stirring speed of 400 r/min;
(4) Adding the component C, stirring and mixing uniformly, and preserving heat for 20min;
(5) Cooling to 48deg.C, adding component D, stirring at 400r/min for 20min, and mixing to obtain acne-removing composition.
Example 6
The difference from example 2 is that the licorice extract was replaced with an equivalent amount of centella asiatica extract.
Example 7
The difference from example 2 is that the pagodatree flower extract is replaced with the equivalent amount of centella asiatica extract.
Example 8
The difference from example 2 is that the cynanchum atratum extract is replaced with an equivalent amount of centella asiatica extract.
Example 9
The difference from example 2 is that the active substance is replaced by an equivalent amount of centella asiatica extract.
Example 10
The difference from example 2 is that the mass ratio of cynanchum atratum extract/centella asiatica root extract/sophora japonica extract/licorice extract is 5:80:3:12.
Example 11
The difference from example 2 is that the mass ratio of cynanchum atratum extract/centella asiatica root extract/sophora japonica extract/licorice extract is 25:55:18:2.
Example 12
The difference from example 2 is that the mass ratio of dextrin, salicylic acid and sesame amino acids is 61:38:1.
Example 13
The difference from example 2 is that the mass ratio of dextrin, salicylic acid and sesame amino acids is 67:32:1.
Experimental example 1
Safety evaluation
The experimental object: randomly selecting 60 women aged 20-50 years, requiring skin health without skin allergy history;
the experimental method comprises the following steps: a qualified patch tester is selected, about 0.020g-0.025g of the acne removing composition obtained in the examples 1-13 of the invention is added into the patch tester in a closed patch test mode, a special adhesive tape is externally used for coating the back of a subject, the test substance is removed after 24 hours, skin reactions are observed after 0.5, 6, 12, 24 and 48 hours respectively, and the results are recorded according to the skin reaction grading standard in cosmetic hygiene Specification.
Experimental results: the test results of the human skin patch show that after the acne removing composition obtained in the examples 1-13 is used, skin irritation reactions such as erythema, edema, pimple, stinging and the like do not appear in all groups of subjects within 48 hours, which indicates that the acne removing composition provided by the invention is safe to use.
Experimental example 2
Efficacy evaluation
Propionibacterium acnes antibacterial test
Preparation of a bilayer plate (15 mL of medium in the lower layer and 5mL of medium containing Propionibacterium acnes in the upper layer) containing Propionibacterium acnes (ATCC 11827) with a plate bacterial load of about 10 5 And (3) placing 2 oxford cups vertically on the surface of each flat plate, respectively taking 200uL of acne removing composition, placing into the oxford cups, performing anaerobic culture for 24 hours at the temperature of 36+/-1 ℃, and then measuring the diameter of a bacteriostasis ring for judging the bacteriostasis effect on propionibacterium acnes. The criteria are shown in table 2 below:
TABLE 2
| Acne removing effect | Diameter D (mm) of inhibition zone |
| Efficient | D≥20 |
| Middle effect | 15≤D＜20 |
| Low efficiency | 10≤D＜15 |
| Invalidation of | D＜10 |
The results of the antibacterial experiments of the acne-removing compositions obtained in examples 1 to 11 of the present invention are shown in the following table 3, and in order to eliminate the influence of other preservatives on the antibacterial effect, no preservative o-cymene-5-ol was added to the samples subjected to the acne-removing efficacy test. The results show that: the acne-removing composition provided by the invention has a good acne-removing effect and thus has a good acne-removing effect; the anti-acne composition obtained in examples 6-9 has a significantly lower diameter of the inhibition zone than that of example 2, and has relatively poor anti-acne effect, so that the anti-acne effect is improved by using the cynanchum atratum extract, the pagodatree flower extract, the licorice extract and the centella asiatica root extract in combination.
TABLE 3 Table 3
| Group of | Diameter D (mm) of inhibition zone | Acne removing effect |
| Example 1 | 30.8 | Efficient |
| Example 2 | 32.1 | Efficient |
| Example 3 | 31.7 | Efficient |
| Example 4 | 22.8 | Efficient |
| Example 5 | 24.2 | Efficient |
| Example 6 | 27.6 | Efficient |
| Example 7 | 19.2 | Middle effect |
| Example 8 | 18.7 | Middle effect |
| Example 9 | 15.8 | Middle effect |
| Example 10 | 23.5 | Efficient |
| Example 11 | 24.7 | Efficient |
| Example 12 | 30.5 | Efficient |
| Example 13 | 29.8 | Efficient |
(II) acne-removing effect experiment
Randomly selecting 110 volunteers with acne of II degree or above, and ages 15-30, and male and female halves; the acne-removing composition is applied after the face is cleaned by warm water in the morning and evening every day, and is gently rubbed to the skin to be absorbed, and the acne-removing effect is observed after 2 weeks.
Acne grading criteria: i degree: skin lesions are comedones, sporadic or multiple inflammatory rashes; II degree: superficial abscess with I degree, the number of inflammations is large, but the method is limited to the face; III degree: the second degree deepens inflammatory rash, which may have cysts, occurring on the face, neck, chest and back; IV degree: and III, adding cyst, and easily forming scar which occurs on the upper body.
The experimental results are shown in table 4 below.
TABLE 4 Table 4
The results show that: the acne-removing composition obtained in the embodiments 1-3 has an acne-removing effect up to 100%, and has a remarkable acne-removing effect; the acne-removing effect of the acne-removing composition obtained in the examples 4 and 5 is inferior to that of the acne-removing composition obtained in the examples 1 to 3, and the proportion of each component in the acne-removing composition has a larger influence on the acne-removing effect; the acne-removing effect of the acne-removing composition obtained in examples 6-11 is obviously inferior to that of example 2, and the acne-removing effect of the acne-removing composition can be effectively improved by utilizing the combination of the cynanchum atratum extract, the pagodatree flower extract, the liquorice extract and the centella asiatica root extract.
(III) oil control effect experiment
72 volunteers with more vigorous skin grease secretion are randomly selected, the ages of 18-40 years and men and women are half-aged, the right forehead half part of the subject is selected as an experimental area, and the left forehead half part is selected as a control area. After volunteers under certain temperature and humidity conditions for 30min, measuring sebum value by using a SEBUMETER method by using a SEBUMETER SM815 sebum measuring instrument, and recording as T0; the acne-removing composition of the present invention was then applied at 1.25. Mu.L/cm 2 Uniformly applying the amount of (2) to the right half of forehead until absorption, measuring the sebum value at the moment, marking as T1, and then measuring the sebum value after 0.5, 1 and 2 hours; the change rate of the oil content is calculated as follows:
the change rate of the oil content= (oil content after application-oil content before application)/oil content before application×100%.
The experimental results are shown in table 5 below.
TABLE 5
The results show that: the acne-removing composition obtained in the embodiments 1-3 of the invention shows good oil control effect within 2 hours of application; the oil control effect of the acne-removing mixture obtained in comparative examples 4-11 is poorer than that of example 2, and it is seen that the proportion of the acne-removing composition, the type and proportion of active substances influence the oil control effect of the product, and better oil control effect can be obtained by taking the cynanchum atratum extract, the pagodatree flower extract, the licorice extract and the centella asiatica root extract as active substances; the oil control effect of the acne-removing mixture obtained in examples 12 and 13 is inferior to that of example 2, and it is seen that the proportion of the adsorbents dextrin, salicylic acid and sesaminic acid affects the absorption of the product, thereby affecting the oil control effect.
Experimental example 3
Stability test
The anti-acne compositions obtained in examples 1 to 13 of the present invention were subjected to various storage conditions for 3 months of stability observation, and the results are shown in Table 6 below.
TABLE 6
The results show that: the acne-removing composition obtained in the examples 1-3 has no obvious change after being stored for 30 months at different temperatures, and the color and the shape are consistent with those of the acne-removing composition before experiments, which shows that the acne-removing composition provided by the invention has good stability; the acne-removing composition obtained in examples 12 and 13 has deep color and small morphological change after being stored for 3 months at 40 ℃ and 50 ℃, which indicates that the dextrin, the salicylic acid and the sesame amino acid are added in a specific proportion, so that the long-term stability of the product can be improved, the use convenience and the portability are improved, and the acne-removing cosmetic can meet the demands of people at any time.
The previous description of the embodiments is provided to facilitate a person of ordinary skill in the art in order to make and use the present invention. It will be apparent to those skilled in the art that various modifications can be readily made to these embodiments and the generic principles described herein may be applied to other embodiments without the use of the inventive faculty. Therefore, the present invention is not limited to the above-described embodiments, and those skilled in the art, based on the present disclosure, should make improvements and modifications without departing from the scope of the present invention.
Claims (16)
1. An anti-acne composition comprises an active, an emulsifier, an emollient, a humectant, a surfactant, an antioxidant, a skin conditioning agent, an adsorbent, an emulsion stabilizer, a thickener, a preservative, a chelating agent, a cooling agent, a fragrance, and a solvent; wherein,
the active substances comprise cynanchum atratum extract, centella asiatica root extract, sophora japonica extract and liquorice extract in a mass ratio of 10-20:60-75:8-15:4-10;
the adsorbent comprises dextrin, salicylic acid and sesame amino acid in a mass ratio of 62.8-65.6:34-37:0.2-0.4; the mass ratio of the active substances is 2-5%.
2. The acne-removing composition according to claim 1, wherein the active substance comprises cynanchum atratum extract, centella asiatica root extract, sophora japonica extract and licorice extract in a mass ratio of 10:16:70:4.
3. The acne-removing composition according to claim 1, wherein the emulsifier is at least one of cetostearyl alcohol, polysorbate-60, glycerol stearate, PEG-100 stearate, sorbitan sesquioleate, dimerized hydroxystearate, behenyl alcohol and arachidyl alcohol glucoside, lauric acid, myristic acid, palmitic acid, glycerol stearate, glycerol.
4. The anti-acne composition of claim 1, wherein the emollient is at least one of ethylhexyl palmitate, hexyl laurate, lauryl alcohol, squalane, caprylic triglyceride, capric triglyceride, polydimethylsiloxane, and jojoba seed oil.
5. The acne-removing composition according to claim 1, wherein the humectant is at least one of polydimethylsiloxane, glycerin, propylene glycol, butylene glycol, 1, 2-pentanediol, 1, 2-hexanediol, polyethylene glycol, quaternary ammonium salt-73, inositol, sarcosine, dipeptide-15, xylitol, sorbitol, sodium hyaluronate and isopropyl palmitate, and hydrolyzed glucosamine.
6. The acne-removing composition according to claim 1, wherein the surfactant is at least one of sorbitan stearate, disodium lauryl sulfosuccinate, lecithin, stearic acid, sodium dodecylbenzenesulfonate, sodium dodecylsulfate, polysorbate, and fatty acid glyceride.
7. The acne-removing composition according to claim 1, wherein the antioxidant is at least one of p-hydroxyacetophenone, tocopherol, di-t-butyl-p-cresol, t-butyl hydroxyanisole, and propylated caproate.
8. The acne-removing composition according to claim 1, wherein the skin conditioner is at least one of allantoin, liquid paraffin, liquid petrolatum, isopropyl myristate, isopropyl palmitate, 2-ethylhexyl palmitate, unsaturated fatty acids.
9. The acne-removing composition according to claim 1, wherein the adsorbent comprises dextrin, salicylic acid and sesaminic acid in a mass ratio of 64.8:35:0.2.
10. The acne-removing composition according to claim 1, wherein the emulsion stabilizer is at least one of polyacrylate-13, polyisobutylene, sorbitan isostearate, polysorbate-20, vitamin E acetate, butylated hydroxytoluene, t-butyl-p-methoxyphenol, and propyl gallate.
11. The acne-removing composition of claim 1, wherein the thickener is at least one of isopropyl myristate, xanthan gum, beeswax, xanthan gum, acrylic polymer, carrageenan, carbomer, pectin, and cellulose.
12. The acne-removing composition according to claim 1, wherein the cooling agent is menthol and the chelating agent is EDTA-disodium.
13. The acne-removing composition according to any one of claims 1 to 12, comprising, in weight percent:
component A:6-15% isopropyl myristate, 3-5% cetostearyl alcohol, 1.5-4% ethylhexyl palmitate, 1.5-3% polysorbate-60, 0.8-2% glyceryl stearate/PEG-100 stearate, 1-2% dimethicone, 1.2-2% sorbitan stearate, 0.2-0.8% myristic acid/glyceryl stearate/glycerin, and 0.1-0.5% tocopherol; component B:50-60% of solvent, 3-6% of glycerol, 0.2-0.6% of p-hydroxyacetophenone, 0.1-0.5% of xanthan gum, 0.1-0.3% of allantoin, 0.03-0.08% of cymene-5-ol and 0.02-0.06% of EDTA-disodium;
component C:1.5-3% dextrin/salicylic acid/sesame amino acids, 0.8-1.5% polyacrylate-13/polyisobutylene/sorbitan isostearate/polysorbate-20 and 0.1-0.3% menthol;
component D:0.25-0.56% water, 1.5-3% butanediol/1, 2-pentanediol, 2-5% active substance, 1.3-2% propylene glycol/quaternary ammonium salt-73, 0.2-0.6%1, 2-hexanediol, 0.2-0.6% inositol, 0.3-0.8% butanediol/sarcosine/inositol/dipeptide-15, and 0.1-0.3% essence.
14. The acne-removing composition according to claim 13, comprising, in weight percent: component A:10% isopropyl myristate, 4.4% cetostearyl alcohol, 3.5% ethylhexyl palmitate, 2.5% polysorbate-60, 2% glyceryl stearate/PEG-100 stearate, 1.7% dimethicone, 1.8% sorbitan stearate, 0.55% myristic acid/glyceryl stearate/glycerin, and 0.4% tocopherol; component B:55% solvent, 4.2% glycerol, 0.3% p-hydroxyacetophenone, 0.3% xanthan gum, 0.2% allantoin, 0.05% cymene-5-ol and 0.04% edta-disodium;
component C:2% dextrin/salicylic acid/sesame amino acid, 1% polyacrylate-13/polyisobutylene/sorbitan isostearate/polysorbate-20, 0.2% menthol;
component D:0.36% water, 2% butanediol/1, 2-pentanediol, 4% active substance, 2% propylene glycol/quaternary ammonium salt-73, 0.3%1, 2-hexanediol, 0.5% inositol, 0.5% butanediol/sarcosine/inositol/dipeptide-15, and 0.2% perfume.
15. The method for preparing the acne-removing composition according to any one of claims 13 to 14, comprising the steps of:
(1) Adding the component A into an oil phase pot, and heating and uniformly stirring to obtain an oil phase mixed solution A;
(2) Adding the component B into a water phase pot, and heating and stirring uniformly to obtain a water phase mixed solution B;
(3) Preheating a reaction kettle, vacuumizing and sucking the oil phase mixed solution A and the water phase mixed solution B, and starting stirring to perform homogenizing emulsification;
(4) Adding the component C, stirring and uniformly mixing, and preserving heat;
(5) Cooling to 45-50deg.C, adding component D, stirring and mixing
And (5) uniformly obtaining the acne-removing composition.
16. Use of the acne-removing composition of any one of claims 1-14 in the preparation of a cosmetic.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310930353.0A CN116869886B (en) | 2023-07-27 | 2023-07-27 | Acne-removing composition, and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310930353.0A CN116869886B (en) | 2023-07-27 | 2023-07-27 | Acne-removing composition, and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116869886A CN116869886A (en) | 2023-10-13 |
| CN116869886B true CN116869886B (en) | 2024-04-02 |
Family
ID=88256711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310930353.0A Active CN116869886B (en) | 2023-07-27 | 2023-07-27 | Acne-removing composition, and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116869886B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105380830A (en) * | 2015-12-02 | 2016-03-09 | 广州豆乎生物科技有限公司 | Composition capable of removing pockmarks and inhibiting acne generation, and application thereof |
| CN114028295A (en) * | 2021-12-10 | 2022-02-11 | 北京安德普泰医疗科技有限公司 | Antibacterial itching-relieving red-fading acne-removing repairing composition as well as preparation method and application thereof |
| CN115025024A (en) * | 2022-07-29 | 2022-09-09 | 维怡美生物科技(广州)有限公司 | Acne and acne mark removing composition and application thereof |
| CN115105449A (en) * | 2022-07-19 | 2022-09-27 | 广州陶妆生物科技有限公司 | Novel antibacterial anti-inflammation acne cream and preparation method thereof |
-
2023
- 2023-07-27 CN CN202310930353.0A patent/CN116869886B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105380830A (en) * | 2015-12-02 | 2016-03-09 | 广州豆乎生物科技有限公司 | Composition capable of removing pockmarks and inhibiting acne generation, and application thereof |
| CN114028295A (en) * | 2021-12-10 | 2022-02-11 | 北京安德普泰医疗科技有限公司 | Antibacterial itching-relieving red-fading acne-removing repairing composition as well as preparation method and application thereof |
| CN115105449A (en) * | 2022-07-19 | 2022-09-27 | 广州陶妆生物科技有限公司 | Novel antibacterial anti-inflammation acne cream and preparation method thereof |
| CN115025024A (en) * | 2022-07-29 | 2022-09-09 | 维怡美生物科技(广州)有限公司 | Acne and acne mark removing composition and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116869886A (en) | 2023-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109044915B (en) | Infant hip-protecting cream and preparation process thereof | |
| CN110448486B (en) | Essential oil capable of repairing damaged sebum membrane | |
| CN110638707A (en) | Eye care cream and preparation method thereof | |
| CN113693979B (en) | Oil-control acne-removing composition and application thereof | |
| CN111728907B (en) | Composition for relieving and resisting allergy, preparation method thereof and application thereof in cosmetics | |
| CN110638727B (en) | Infant hip-protecting composition and preparation method and application thereof | |
| CN110859762B (en) | Gel containing Camellia japonica extract and having after-sun repair effect and preparation method thereof | |
| CN117045523A (en) | High-content azelaic acid composition and preparation method thereof | |
| CN113018238A (en) | Anti-bacterial, anti-inflammatory, refreshing and skin-benefiting acne-removing gel and preparation method thereof | |
| CN111557886A (en) | Plant-nourishing efficient moisturizing cream and preparation method thereof | |
| CN113995693B (en) | Essence composition of liposome with anti-inflammatory effect, and preparation method and application thereof | |
| JP4414495B2 (en) | Antibacterial agent, skin external preparation and skin cleansing agent containing the same | |
| CN114848517A (en) | Moisturizing, oil-controlling, anti-inflammatory, bacteriostatic and acne-removing composition, acne-removing cosmetic containing composition and preparation method of acne-removing cosmetic | |
| CN113456570A (en) | Acne-removing composition, acne-removing gel and preparation method thereof | |
| CN116869886B (en) | Acne-removing composition, and preparation method and application thereof | |
| KR20210072966A (en) | Nanocapsule composition for skin moisturizing or skin inflammatory improvement comprsing encapsulated centella and calamine | |
| CN115192488B (en) | Acne-removing and skin-refreshing essence containing betaine salicylate and preparation method thereof | |
| CN114848721B (en) | Acne-removing composition containing plant extracts and application thereof | |
| KR102675013B1 (en) | Composition for improving acne skin comprising hemp seed extract and hemp seed oil | |
| CN110339080A (en) | A kind of lip moisturizing essence dew | |
| CN115670952A (en) | Oil-control anti-acne composition, skin care product and preparation method | |
| CN115919686A (en) | Skin soothing lotion for enhancing skin barrier and preparation method thereof | |
| CN114533578A (en) | Cosmetic composition for removing pustular pox and preparation process thereof | |
| KR102333132B1 (en) | Cosmetic Composition containing Frangipani Oil or Fermented Frangipani Oil | |
| CN109431881B (en) | Tibetan sheep oil for preventing skin from being cracked due to dryness |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |